Livzon Pharmaceutical Group Inc. (SHE:000513)
China
· Delayed Price · Currency is CNY 34.79
+0.10 (0.29%)
Mar 10, 2026, 10:05 AM CST
SHE:000513 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Jan '21 Jan 1, 2021 | 2020 - 2016 |
| Market Capitalization | 27,990 | 30,704 | 28,292 | 27,456 | 32,307 | 33,156 | Upgrade
|
| Market Cap Growth | -3.57% | 8.53% | 3.04% | -15.02% | -2.56% | 19.91% | Upgrade
|
| Enterprise Value | 22,267 | 24,773 | 22,700 | 22,297 | 27,114 | 27,086 | Upgrade
|
| Last Close Price | 34.69 | 36.93 | 32.80 | 29.19 | 34.71 | 34.08 | Upgrade
|
| PE Ratio | 14.55 | 14.90 | 14.48 | 14.38 | 18.19 | 19.33 | Upgrade
|
| Forward PE | 16.44 | 15.83 | 17.25 | 16.36 | 18.28 | 21.60 | Upgrade
|
| PS Ratio | 2.36 | 2.60 | 2.28 | 2.17 | 2.68 | 3.15 | Upgrade
|
| PB Ratio | 1.82 | 2.06 | 1.92 | 1.84 | 2.26 | 2.43 | Upgrade
|
| P/TBV Ratio | 2.10 | 2.30 | 2.10 | 2.08 | 2.56 | 2.82 | Upgrade
|
| P/FCF Ratio | 11.04 | 12.75 | 11.65 | 14.98 | 54.46 | 21.90 | Upgrade
|
| P/OCF Ratio | 8.76 | 10.31 | 8.71 | 9.90 | 16.98 | 15.35 | Upgrade
|
| PEG Ratio | - | 0.29 | 0.29 | 0.29 | 0.29 | 0.29 | Upgrade
|
| EV/Sales Ratio | 1.88 | 2.10 | 1.83 | 1.77 | 2.25 | 2.58 | Upgrade
|
| EV/EBITDA Ratio | 7.70 | 8.03 | 8.28 | 8.70 | 11.58 | 11.19 | Upgrade
|
| EV/EBIT Ratio | 8.82 | 9.77 | 11.81 | 11.54 | 14.14 | 13.35 | Upgrade
|
| EV/FCF Ratio | 8.78 | 10.29 | 9.35 | 12.17 | 45.71 | 17.89 | Upgrade
|
| Debt / Equity Ratio | 0.26 | 0.27 | 0.28 | 0.24 | 0.19 | 0.14 | Upgrade
|
| Debt / EBITDA Ratio | 1.36 | 1.28 | 1.50 | 1.40 | 1.14 | 0.80 | Upgrade
|
| Debt / FCF Ratio | 1.55 | 1.65 | 1.71 | 1.98 | 4.54 | 1.27 | Upgrade
|
| Net Debt / Equity Ratio | -0.46 | -0.46 | -0.49 | -0.46 | -0.46 | -0.59 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.48 | -2.25 | -2.65 | -2.69 | -2.83 | -3.32 | Upgrade
|
| Net Debt / FCF Ratio | -2.81 | -2.88 | -2.99 | -3.77 | -11.18 | -5.32 | Upgrade
|
| Asset Turnover | 0.48 | 0.48 | 0.50 | 0.54 | 0.56 | 0.55 | Upgrade
|
| Inventory Turnover | 2.31 | 2.09 | 2.33 | 2.47 | 2.74 | 2.82 | Upgrade
|
| Quick Ratio | 1.95 | 1.87 | 1.86 | 1.97 | 1.83 | 2.13 | Upgrade
|
| Current Ratio | 2.25 | 2.15 | 2.13 | 2.30 | 2.12 | 2.40 | Upgrade
|
| Return on Equity (ROE) | 16.43% | 15.53% | 12.78% | 13.37% | 13.97% | 16.45% | Upgrade
|
| Return on Assets (ROA) | 6.38% | 6.40% | 4.81% | 5.11% | 5.58% | 6.58% | Upgrade
|
| Return on Invested Capital (ROIC) | 26.24% | 26.92% | 19.70% | 20.64% | 25.12% | 33.56% | Upgrade
|
| Return on Capital Employed (ROCE) | 14.70% | 15.10% | 11.30% | 11.10% | 12.40% | 14.00% | Upgrade
|
| Earnings Yield | 7.65% | 6.71% | 6.91% | 6.95% | 5.50% | 5.17% | Upgrade
|
| FCF Yield | 9.06% | 7.85% | 8.58% | 6.67% | 1.84% | 4.57% | Upgrade
|
| Dividend Yield | 3.16% | 2.98% | 4.12% | 5.48% | 3.75% | 3.67% | Upgrade
|
| Payout Ratio | 48.57% | 65.03% | 81.36% | 83.33% | 70.81% | 64.14% | Upgrade
|
| Buyback Yield / Dilution | 2.91% | 1.10% | 0.56% | 0.04% | 0.25% | -0.41% | Upgrade
|
| Total Shareholder Return | 6.07% | 4.08% | 4.68% | 5.52% | 4.00% | 3.26% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.